• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

ACP-105 Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5754473

ACP-105 is a selective amd potent androgen receptor modulator (SARM). For AR wild type and T877A mutant, the pEC50s values are 9.0 and 9.3, respectively. More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
ACP-105, Inhibitor
Full Product Name
ACP-105
Product Gene Name
Form/Format
Solid. Powder
Purity/Purification
98.00%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
290.79
Solubility
DMSO: 103mg/mL (354.21mM)
(<1mg/ml refers to the product slightly soluble or insoluble)
Formula
C16H19ClN2O
SMILES
N#CC1=CC=C(N2[C@@H]3C[C@](O)(C)C[C@H]2CC3)C(C)=C1Cl
CAS Number
899821-23-9
Target & IC50
AR wild type: ic50 9.0 (pEC50)
AR T877A mutant: ic50 9.3 (pEC50)
In Vitro
ACP-105 is an orally available, selective amd potent androgen receptor modulator (SARM), with pEC50s of 9.0 and 9.3 for AR wild type and T877A mutant, respectively. The half-lives of ACP-105 (compound 1) in human hepatocytes is measured and found to be 5.0 h[1].

Structure of ACP-105, inhibitor

ACP-105 Inhibitor – Cat# MBS5754473

Product References and Citations for ACP-105, inhibitor

Schlienger N, et al. Synthesis, structure-activity relationships, and characterization of novel nonsteroidal and selective androgen receptor modulators. J Med Chem. 2009 Nov 26;52(22):7186-91.
Schlienger N, et al. Synthesis, structure-activity relationships, and characterization of novel nonsteroidal and selective androgen receptor modulators. J Med Chem. 2009 Nov 26;52(22):7186-91.
Dayger C, et al. Effects of the SARM ACP-105 on rotorod performance and cued fear conditioning in sham-irradiated and irradiated female mice. Brain Res. 2011 Mar 24;1381:134-40.
Dayger C, et al. Effects of the SARM ACP-105 on rotorod performance and cued fear conditioning in sham-irradiated and irradiated female mice. Brain Res. 2011 Mar 24;1381:134-40.

Other Notes

Small volumes of ACP-105, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for ACP-105 purchase

MBS5754473 is an inhibitor targeting ACP-105.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000